BioAuxilium completes development of its 100th TR-FRET assay kit

Canada based company BioAuxilium specialised in the development of custom TR-FRET assay kit recently announced the successful development of its 100^th custom TR-FRET immunoassay kit.

These easy-to-use, fully validated assay kits provide researchers with homogeneous, robust and highly sensitive assays that simplify laboratory workflow and accelerate drug discovery and life science research.

They use the robust TR-FRET technology, which combines the sensitivity and low background of time-resolved fluorescence with the homogeneous nature of FRET. This technology does not require plate coating, washing or separation steps, thereby allowing considerable time-savings compared with standard ELISA.

Jaime Padros, Ph.D., President, BioAuxilium said, "BioAuxilium is responding to an increasing demand for custom assay kit development using the TR-FRET technology. We are very pleased to have quickly reached this important milestone. These custom products were developed and validated within a 15-month timeframe period, which highlights our experience and expertise in assay reagent and kit development."

"Our custom assay kit development service brings together our industry-validated new product development process, in depth knowledge of TR-FRET and expert scientific insight that allow our partners to mitigate risks, manage costs and meet aggressive timelines", he added